Skip to content
Lung cancer screening

The complete solution for lung cancer screening programs

The Optellum Lung Cancer Screening (LCS) solution is built to help health systems, hospitals, and imaging centers manage their lung cancer screening programs efficiently and precisely

Optellum is trusted by industry & academic leaders

  • oxford
  • nhs
  • vumc
  • Uconn-health
  • penn-medicine-1
  • jupiter medical
  • johnson and johnson
  • intuitive
  • georgia cancer centre
  • ge-healthcare
  • concert-ai
  • Atrium health
The problem

Major gaps in lung cancer screening undermine early detection and increase the risk of upstaging

Lung cancer screening programs continue to struggle with poor uptake, low adherence, and fragmented management. Missed or late follow-up scans allow treatable nodules to progress, leading to more advanced diagnoses and higher morbidity, mortality, and overall costs

40%

of patients do not return for their first follow-up annual screening1

47%

of positive cases have delayed follow-up as per guidelines2

104 days

median delay for follow-up of positive cases2

Introducing Optellum's Lung Cancer Screening solution

Centralize patient tracking, streamline follow-ups, and integrate seamlessly with your EHR and PACS

The Optellum LCS solution helps health systems, hospitals, and imaging centers:

  • Centralize patient management in a single unified dashboard
  • Track patient follow-up with automated alerts to ensure patient retention
  • Facilitate patient communication with letter generation and export
  • Provide automated access to CT images and radiology reports
  • Automate data entry via integration with EHR (HL7) & PACS (DICOM)
Letter-generating-V2

Automatically access CT images and reports, and extract key information such as Lung-RADS

demo-screening-02-2026-2048x962-1
enrolled-patients-02-2026-2048x1161
Empower your lung cancer screening program with the most advanced and accurate technology available

Footnotes

1. Kim et al 2025
2. Ahmed et al 2023
Certification

Redefining early intervention of lung disease starting with one of the deadliest, lung cancer